Enveda Biosciences fetches $51m Series A
Enveda Biosciences, a biotechnology company, has raised $51 million in Series A funding.
Enveda Biosciences, a biotechnology company, has raised $51 million in Series A funding.
Copyright PEI Media
Not for publication, email or dissemination